{'fraction_non_alphanumeric': 0.022900763358778626, 'fraction_numerical': 0.0, 'mean_word_length': 5.818181818181818, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Serum protein N‐glycosylation in paediatric non‐alcoholic fatty liver disease

We have previously shown the potential of glycomics to distinguish patients with steatosis from patients with non‐alcoholic steatohepatitis (NASH) in an adult population. The pattern of disease in paediatric patients is distinct from adults. The objective of this study was to characterize the N ‐glycomic profile of children with varying degrees of non‐alcoholic fatty liver disease (NAFLD) and identify potential biomarker profiles of disease.